Biological characterization of Pseudomonas aeruginosa endotoxin released by antibiotic treatment in vitro

Journal of Endotoxin Research

Volumn 3, Issue 3, 1996, Pages 195-200

  Nakano, Masayasu ^a   Kirikae, Teruo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CEFTAZIDIME; ENDOTOXIN; GALACTOSAMINE; IMIPENEM; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; OFLOXACIN; POLYMYXIN B; SODIUM CHLORIDE; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ESCHERICHIA COLI; INTRAPERITONEAL DRUG ADMINISTRATION; LETHALITY; LIMULUS LYSATE TEST; MACROPHAGE ACTIVATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PSEUDOMONAS AERUGINOSA; SENSITIZATION; SERUM FACTOR;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LIMULUS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0029743097     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199600300305     Document Type: Conference Paper

References (21)

1. Parillo J.E., Parker M.M., Natanson C. et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113: 227-241.
2. Leeson M.C., Fujihara Y., Morrison D.C. Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria. Infect Immun 1994; 62: 4975-4980.
3. Dofferhoff A.S.M., Buys J. Dose- and type-dependent antibiotic-induced endotoxin release. In: Faist E. Ed. Differential Release and Impact of Antibiotic-induced Endotoxin. Whitehouse Station: Merck, 1995; 11-19.
4. Jackson J.J., Kropp H. Carbapenem- and cephalosporin-induced release of lipopolysaccharide from smooth and rough Pseudomonas aeruginosa: in vivo relevance. In: Faist E. Ed. Differential Release and Impact of Antibiotic-induced Endotoxin. Whitehouse Station: Merck, 1995; 21-35.
5. Neu H.C. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Am J Med 1985; 79 (Suppl 1A): 2-13.
6. Tuomanen E., Gilbert K., Tomasz A. Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli. Antimicrob Agents Chemother 1986; 30: 659-663.
7. Morrison D.C., Danner R.L., Dinarello C.A. et al. Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction. J Endotoxin Res 1994; 1: 71-83.
8. Westphal O., Lüderitz O., Bister F. Uber die Extraktion von Bakterien mit Phenol/Wasser. Naturforschung 1952; 7b: 148-155.
9. Tamura H., Arimoto Y., Tanaka S., Yoshida M., Obayashi T., Kawai T. Automated kinetic assay for endotoxin and (1→3)-β-D-glucan in human blood. Clinica Chimica Acta 1994; 226: 109-112.
10. Atlas R.M., Parks L.C. M9 medium. In: Handbook of Microbiological Media. Boca Raton, FL: CRC Press, 1993; 529.
11. Obayashi T., Tamura H., Tanaka S., Ohki M., Takahashi S., Kawai T. Endotoxin-inactivating activity in normal and pathological human blood samples. Infect Immun 1986; 53: 294-297.
12. Galanos C., Freudenberg M.A., Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979; 75: 5939-5943.
13. Morrison D.C., Betz S.J., Jacobs D.M. Isolation of lipid A bound polypeptide responsible for 'LPS-initiated' mitogenesis of C3H/HeJ spleen cells. J Exp Med 1976; 144: 840-846.
14. Manthey C.L., Vogel S.N. Elimination of trace endotoxin protein from rough chemotype LPS. J Endotoxin Res 1994; 1: 84-91.
15. Kirikae F., Kirikae T., Qureshi N., Takayama K., Morrison D.C., Nakano M. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect Immun 1995; 63: 486-497.
16. Shinomiya H., Hirata H., Nakano M. Purification and characterization of the 65-kDa protein phosphorylated in murine macrophages by stimulation with bacterial lipopolysaccharide. J Immunol 1991; 146: 3617-3625.
17. Beaty C.D., Franklin T.L., Uehara Y., Wilson C.B. Lipopolysaccharide-induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. Eur J Immunol 1994; 24: 1278-1284.
18. Weinstein S., Sanghera J.S., Lemke K., DeFranco A.L., Pelech S.L. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J Biol Chem 1992; 267: 14955-14962.
19. Schumann R.R., Leong S.R., Flaggs G.W. et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-1431.
20. Wright S.D., Ramos R.A., Patel M., Miller D.S. Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by SD 14 on phagocytes. J Exp Med 1992; 176: 719-727.
21. Kirikae T., Schade F.U., Kirikae F., Rietschel E.T., Morrison D.C. Isolation of a macrophage-like cell line defective in binding of lipopolysaccharide. Influence of serum and lipopolysaccharide chain length on macrophage activation. J Immunol 1993; 151: 2742-2752.